In TB, an 8-wk, 5-drug regimen was noninferior to a standard 24-wk, 4-drug regimen for clinical outcomes at 96 wk
Sacks HS
Annals of internal medicine · 2023-06
Abstract
Source citation Paton NI, Cousins C, Suresh C, et al; TRUNCATE-TB Trial Team. Treatment strategy for rifampin-susceptible tuberculosis. N Engl J Med. 2023;388:873-887. 36808186.
MeSH terms
- Humans
- Tuberculosis
- Rifampin
- Antitubercular Agents
- Drug Therapy, Combination